Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AR | P10275 | 1/20 | 0.45 |
| ▸ | PTPN5 | P54829 | 2/20 | 0.43 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.43 |
| ▸ | XDH | P47989 | 1/20 | 0.39 |
| ▸ | CTSS | P25774 | 2/20 | 0.37 |
| ▸ | CTSK | P43235 | 2/20 | 0.37 |
| ▸ | CNR1 | P21554 | 1/20 | 0.36 |
| ▸ | CNR2 | P34972 | 1/20 | 0.36 |
| ▸ | KIF11 | P52732 | 1/20 | 0.36 |
| ▸ | PARP10 | Q53GL7 | 1/20 | 0.36 |
| ▸ | PARP11 | Q9NR21 | 1/20 | 0.36 |
| ▸ | ICMT | O60725 | 1/20 | 0.36 |
| ▸ | ASIC3 | Q9UHC3 | 1/20 | 0.36 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.35 |
| ▸ | MAOB | P27338 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
| ▸ | RAB9A | P51151 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12148972 | 1.00 | AR (0.45) | ARPTPN5PDK2XDHCTSS | |
| SCHEMBL12198263 | 0.93 | CTSS (0.42) | ARPDK2XDHCTSSCTSK | |
| SCHEMBL12118000 | 0.93 | CTSS (0.42) | ARPDK2XDHCTSSCTSK | |
| SCHEMBL10075602 | 0.90 | CTSS (0.43) | ARPDK2XDHCTSSCTSK | |
| SCHEMBL2755929 | 0.86 | AR (0.42) | ARPTPN5PDK2XDHCTSS | |
| SCHEMBL12114441 | 0.85 | AR (0.41) | ARPTPN5PDK2XDHCTSS | |
| SCHEMBL12148646 | 0.85 | AR (0.41) | ARPTPN5PDK2XDHCTSS | |
| SCHEMBL12117580 | 0.85 | RXRA (0.39) | ARPDK2XDHCTSSCTSK | |
| SCHEMBL12148953 | 0.85 | RXRA (0.39) | ARPDK2XDHCTSSCTSK | |
| SCHEMBL24487603 | 0.83 | ABL1 (0.39) | XDHCTSSCTSKKIF11PARP10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8288013-B2 | Material for organic electroluminescence device and organic electroluminescence device | IDEMITSU KOSAN CO., LTD. (JP) | 2012-10-16 | — | — | US | disclosed |
| US-20100019659-A1 | MATERIAL FOR ORGANIC ELECTROLUMINESCENCE DEVICE AND ORGANIC ELECTROLUMINESCENCE DEVICE | IDEMITSU KOSAN CO., LTD (JP) | 2010-01-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100019659-A1 | MATERIAL FOR ORGANIC ELECTROLUMINESCENCE DEVICE AND ORGANIC ELECTROLUMINESCENCE DEVICE | CYP19A1, ESR1, KCNH3 | AR 194/4885PTPN5 4375/4885PDK2 1033/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.